Glycine

Glycine

SCHEMBL5386703

NCC(=O)O.Oc1ccc2cc1-2

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 3/20 0.44
▸ ALOX5 P09917 2/20 0.42
▸ GLRA1 P23415 1/20 0.42
▸ SLC6A9 P48067 1/20 0.42
▸ OR51E2 Q9H255 1/20 0.42
▸ RARA P10276 1/20 0.41
▸ RARB P10826 1/20 0.41
▸ RARG P13631 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ GAA P10253 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ HIF1A Q16665 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ RGS12 O14924 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ APEX1 P27695 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL1662353 0.80 RARA (0.47) BACE1ALOX5RARARARBRARG
Ethylamine SCHEMBL11810037 0.80 ALOX5 (0.50) BACE1ALOX5RARARARBRARG
Methylamine SCHEMBL28044974 0.77 — —
Pyruvate SCHEMBL935493 0.77 RARA (0.45) BACE1ALOX5RARARARBRARG
Glycine SCHEMBL252376 0.77 GLRA1 (0.62) GLRA1SLC6A9OR51E2LMNAGAA
Glycine SCHEMBL4201161 0.75 GLRA1 (0.42) BACE1GLRA1SLC6A9OR51E2KDM4E
Methane SCHEMBL28580924 0.74 APP (0.41) BACE1ALOX5RARARARBRARG
Formic Acid SCHEMBL27598190 0.73 APP (0.44) BACE1ALOX5RARARARBRARG
SCHEMBL29171599 0.72 APP (0.48) BACE1ALOX5RARARARBRARG
Boric Acid SCHEMBL29171600 0.72 APP (0.48) BACE1ALOX5RARARARBRARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7183319-B2 Phenylethylamine derivatives and their use in the treatment of melanoma RILEY PATRICK ANTHONY 2007-02-27 — — US disclosed
EP-1427694-A4 FLUORINE-CONTAINING COMPOUNDS AND POLYMERS DERIVED THEREFROM HONEYWELL INT INC (US) 2005-06-22 — — EP disclosed
EP-1451235-A4 FLUORINE-CONTAINING COMPOUNDS AND POLYMERS DERIVED THEREFROM HONEYWELL INT INC (US) 2005-06-22 — — EP disclosed
US-6809216-B2 WATERPROOFING, OIL REPELLENTS, ANTISOILANTS HONEYWELL INTERNATIONAL INC. 2004-10-26 — — US disclosed
US-6800788-B2 FLUORINE-CONTAINING COMPOUNDS, AND POLYMERS DERIVED THEREFROM, FOR USE IN COMPOSITIONS USED FOR TREATING TEXTILE SUBSTRATES. ALSO PROVIDED ARE METHODS OF MAKING FLUORINE-CONTAINING COMPOUNDS AND POLYMERS DERIVED THEREFROM, COMPOSITIONS HONEYWELL INTERNATIONAL INC. 2004-10-05 — — US disclosed
EP-1451235-A2 FLUORINE-CONTAINING COMPOUNDS AND POLYMERS DERIVED THEREFROM Honeywell International Inc. (US) 2004-09-01 — — EP disclosed
EP-1427694-A1 FLUORINE-CONTAINING COMPOUNDS AND POLYMERS DERIVED THEREFROM Honeywell International Inc. (US) 2004-06-16 — — EP disclosed
US-20040029967-A1 Phenylethylamine derivatives and their use in the treatment of melanoma RILEY PATRICK ANTHONY (GB) 2004-02-12 — — US disclosed
US-20030109626-A1 Fluorine-containing compounds and polymers derived therefrom HONEYWELL INTERNATIONAL INC. 2003-06-12 — — US disclosed
US-20030092828-A1 Fluorine-containing compounds and polymers derived therefrom BRADLEY DAVID E (US) 2003-05-15 — — US disclosed
WO-2002103103-A2 FLUORINE-CONTAINING COMPOUNDS AND POLYMERS DERIVED THEREFROM HONEYWELL INTERNATIONAL INC. (US) 2002-12-27 — — WO disclosed
WO-2002102758-A1 FLUORINE-CONTAINING COMPOUNDS AND POLYMERS DERIVED THEREFROM HONEYWELL INTERNATIONAL, INC. (US) 2002-12-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030109626-A1 Fluorine-containing compounds and polymers derived therefrom WASF2, NOTUM, NEFM BACE1 1224/4885ALOX5 451/4885GLRA1 4244/4885
US-20040029967-A1 Phenylethylamine derivatives and their use in the treatment of melanoma DOHH, DBH, HRH4 BACE1 3633/4885ALOX5 2907/4885GLRA1 897/4885
US-20030092828-A1 Fluorine-containing compounds and polymers derived therefrom WASF2, NOTUM, PFAS BACE1 1172/4885ALOX5 527/4885GLRA1 4342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback